Cargando…
Phase 1 Study of the Pharmacology of BTI320 Before High‐Glycemic Meals
BTI320 is a proprietary fractionated mannan polysaccharide being studied for attenuation of postprandial glucose excursion. The apparent blood glucose‐lowering effect of this compound is effective in lowering postprandial hyperinsulinemia, participating in the metabolic regulation of other lipid mol...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585810/ https://www.ncbi.nlm.nih.gov/pubmed/29870598 http://dx.doi.org/10.1002/cpdd.583 |